Acadia Pharmaceuticals (ACAD) Selling, General & Administrative (2010 - 2026)
Acadia Pharmaceuticals' Selling, General & Administrative came in at $160.25 million for Q2 2026, up 20.0% from $133.51 million a year earlier but down 6.3% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Acadia Pharmaceuticals reported Selling, General & Administrative of $620.29 million, up 18.5% year-over-year; for FY2025, it came in at $548.89 million, up 12.4% from FY2024.
- Selling, General & Administrative has increased in each of the last three years, with a five-year compound annual growth rate of 7.1% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $488.43 million in FY2024 (+20.1%), $406.56 million in FY2023 (+10.2%), $369.09 million in FY2022 (-6.8%) and $396.03 million in FY2021 (+1.9%).
- The five-year range for quarterly Selling, General & Administrative is $78.11 million (Q3 2022) to $171.02 million (Q1 2026).
- Year-over-year, Selling, General & Administrative has increased for 14 consecutive quarters, with growth averaging 19.9% over the last eight quarters.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2024 (growth of 36.2%), and the weakest in Q1 2022 (a decline of 13.4%).
- Business Quant data shows ACAD's Selling, General & Administrative at $171.02 million (Q1 2026), $155.62 million (Q4 2025) and $133.4 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Acadia Pharmaceuticals | 3.39 Bn | -84.62 Mn | 279.64 Mn | 160.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 160.25 Mn |
| Mar 31, 2026 | 171.02 Mn |
| Dec 31, 2025 | 155.62 Mn |
| Sep 30, 2025 | 133.40 Mn |
| Jun 30, 2025 | 133.51 Mn |
| Mar 31, 2025 | 126.37 Mn |
| Dec 31, 2024 | 130.08 Mn |
| Sep 30, 2024 | 133.29 Mn |
| Jun 30, 2024 | 117.06 Mn |
| Mar 31, 2024 | 107.99 Mn |
| Dec 31, 2023 | 111.47 Mn |
| Sep 30, 2023 | 97.89 Mn |
| Jun 30, 2023 | 95.97 Mn |
| Mar 31, 2023 | 101.24 Mn |
| Dec 31, 2022 | 104.40 Mn |
| Sep 30, 2022 | 78.11 Mn |
| Jun 30, 2022 | 89.90 Mn |
| Mar 31, 2022 | 96.68 Mn |
| Dec 31, 2021 | 105.91 Mn |
| Sep 30, 2021 | 81.67 Mn |
API Access
Acadia Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();